Kinase mutants and uses thereof
US-2026053803-A1 · Feb 26, 2026 · US
This page is not indexed by search engines while we improve data quality.
Coukos George patents
Coukos George is listed as an inventor on 30 patents in our database. Major assignees and classification codes are summarized below.
| Metric | Value |
|---|---|
| Inventor | Coukos George |
| Total patents | 30 |
| First publication | Oct 5, 2017 |
| Latest publication | Feb 26, 2026 |
Notable patents
Publications ranked by popularity score, then publication date.
Heterodimeric inactivatable chimeric antigen receptors
US-12528847-B2 · Jan 20, 2026 · US
Kinase mutants and uses thereof
US-12478626-B2 · Nov 25, 2025 · US
A2/NY-ESO-1 specific t cell receptors and uses thereof
US-12473346-B2 · Nov 18, 2025 · US
Anti-TEM1 antibodies and antigen-binding portions thereof
US-12297276-B2 · May 13, 2025 · US
Use of urolithin in the remission phase of a preceding cancer therapy
US-2025032447-A1 · Jan 30, 2025 · US
Antisense transfer vectors and methods of use thereof
US-2025009802-A1 · Jan 9, 2025 · US
T cell receptors specific for tumor-associated antigens and methods of use thereof
US-2024327491-A1 · Oct 3, 2024 · US
Single vessel expansion of lymphocytes
US-2024287454-A1 · Aug 29, 2024 · US
Compositions and methods for immunotherapy
US-2024207319-A1 · Jun 27, 2024 · US
Recent patents
Latest publications not already listed above.
Kinase mutants and uses thereof
US-2024180965-A1 · Jun 6, 2024 · US
Compositions and methods for increasing stem cell function
US-2024010981-A1 · Jan 11, 2024 · US
Pd-1 decoy variants for immunotherapy
US-2023414660-A1 · Dec 28, 2023 · US
Compositions and methods for increasing stem cell function
US-2023365933-A1 · Nov 16, 2023 · US
Kinase mutants and uses thereof
US-11738049-B2 · Aug 29, 2023 · US
Car-t cell therapy targeting ngcgm3
US-2023141511-A1 · May 11, 2023 · US
Compositions and methods for immunotherapy
US-2022387555-A1 · Dec 8, 2022 · US
Agents and methods for increasing stem cell function
US-2022241240-A1 · Aug 4, 2022 · US
Anti-tem1 antibodies and antigen-binding portions thereof
US-2022227872-A1 · Jul 21, 2022 · US
Compositions and methods for increasing t cell function
US-2022168271-A1 · Jun 2, 2022 · US
Method for expansion and differentiation of t lymphocytes and nk cells for adoptive transfer therapies
US-2022152107-A1 · May 19, 2022 · US
A2/ny-eso-1 specific t cell receptors and uses thereof
US-2022152109-A1 · May 19, 2022 · US
Anti-TEM1 antibodies and uses thereof
US-11078285-B2 · Aug 3, 2021 · US
Heterodimeric inactivatable chimeric antigen receptors
US-2021113615-A1 · Apr 22, 2021 · US
Method for expansion of lymphocytes
US-2020338125-A1 · Oct 29, 2020 · US
Kinase mutants and uses thereof
US-2020101110-A1 · Apr 2, 2020 · US
Methods and compositions for treating solid tumors and enhancing tumor vaccines
US-2019375845-A1 · Dec 12, 2019 · US
Anti-tem1 antibodies and uses thereof
US-2019194332-A1 · Jun 27, 2019 · US
Anti-TEM1 antibodies and uses thereof
US-10160809-B2 · Dec 25, 2018 · US
Anti-tem1 antibodies and uses thereof
US-2017281793-A1 · Oct 5, 2017 · US
Major assignees
Companies most often associated with this inventor's publications.
| Assignee | Patents |
|---|---|
| Ludwig Inst For Cancer Res Ltd | 25 |
| Centre Hospitalier Univ Vaudois | 8 |
| Univ Of Lausanne | 6 |
| Univ Lausanne | 6 |
| Nestle Sa | 5 |
Top CPC classifications
Most common classification codes across this inventor's patents.
| CPC | Patents |
|---|---|
| A61P35/00 | 18 |
| A61K40/11 | 15 |
| A61K35/17 | 15 |
| C07K14/7051 | 11 |
| A61K2239/38 | 10 |